Hydrogen Gas Shows Promise for Treating COVID-19 Inflammation

Scientists think a special gas called molecular hydrogen might help COVID-19 patients because it can reduce dangerous inflammation and damage inside their cells, though more research is needed to prove it actually works in real patients.

Molecular hydrogen may combat COVID-19 complications by suppressing inflammatory signaling (NF-κB pathway) and activating the body's antioxidant defense system (Nrf2/Keap1 pathway), though clinical evidence remains limited.

This article reviews how molecular hydrogen (H2)—a simple gas molecule—might help treat COVID-19 by reducing inflammation and oxidative stress (cellular damage from unstable molecules). The authors explain that H2 can enter cells easily and activate the body's natural antioxidant defenses while reducing inflammatory signaling. While early studies suggest H2 may be beneficial, the authors note that more rigorous clinical research is needed to confirm whether it actually works in COVID-19 patients.

This is a review article summarizing existing research rather than a new clinical study, and it does not report actual patient results. While the mechanisms described are based on laboratory and some clinical research, the authors explicitly state that H2's true clinical effectiveness in COVID-19 has not yet been established and requires further testing. Anyone considering H2 therapy should consult their healthcare provider, as evidence specific to COVID-19 treatment is still preliminary.

COVID‐19 is a widespread global pandemic with nearly 185 million confirmed cases and about four million deaths. It is caused by an infection with the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), which primarily affects the alveolar type II pneumocytes. The infection induces…

Read the full abstract on PubMed